DK169891B1 - 8alfa-acylaminoergoliner og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende 8alfa-acylaminoergolinerne eller syreadditionssaltene deraf samt 8alfa-acylaminoergolinerne og syreadditionssalte deraf til anvendelse til lægemidler - Google Patents

8alfa-acylaminoergoliner og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende 8alfa-acylaminoergolinerne eller syreadditionssaltene deraf samt 8alfa-acylaminoergolinerne og syreadditionssalte deraf til anvendelse til lægemidler Download PDF

Info

Publication number
DK169891B1
DK169891B1 DK012685A DK12685A DK169891B1 DK 169891 B1 DK169891 B1 DK 169891B1 DK 012685 A DK012685 A DK 012685A DK 12685 A DK12685 A DK 12685A DK 169891 B1 DK169891 B1 DK 169891B1
Authority
DK
Denmark
Prior art keywords
carbon atoms
general formula
alkyl
acid addition
addition salts
Prior art date
Application number
DK012685A
Other languages
Danish (da)
English (en)
Other versions
DK12685A (da
DK12685D0 (da
Inventor
Walter Haefliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK12685D0 publication Critical patent/DK12685D0/da
Publication of DK12685A publication Critical patent/DK12685A/da
Application granted granted Critical
Publication of DK169891B1 publication Critical patent/DK169891B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK012685A 1984-01-12 1985-01-10 8alfa-acylaminoergoliner og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende 8alfa-acylaminoergolinerne eller syreadditionssaltene deraf samt 8alfa-acylaminoergolinerne og syreadditionssalte deraf til anvendelse til lægemidler DK169891B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3400853 1984-01-12
DE3400853 1984-01-12

Publications (3)

Publication Number Publication Date
DK12685D0 DK12685D0 (da) 1985-01-10
DK12685A DK12685A (da) 1985-07-13
DK169891B1 true DK169891B1 (da) 1995-03-27

Family

ID=6224786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK012685A DK169891B1 (da) 1984-01-12 1985-01-10 8alfa-acylaminoergoliner og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende 8alfa-acylaminoergolinerne eller syreadditionssaltene deraf samt 8alfa-acylaminoergolinerne og syreadditionssalte deraf til anvendelse til lægemidler

Country Status (28)

Country Link
US (2) US4950672A (fr)
JP (1) JPH0655739B2 (fr)
AT (1) AT391317B (fr)
AU (3) AU583489B2 (fr)
BE (1) BE901456A (fr)
CA (1) CA1245640A (fr)
CH (1) CH664568A5 (fr)
CY (1) CY1542A (fr)
DE (1) DE3500251C2 (fr)
DK (1) DK169891B1 (fr)
ES (1) ES8605514A1 (fr)
FI (1) FI82466C (fr)
FR (1) FR2560196B1 (fr)
GB (1) GB2152507B (fr)
GR (1) GR850065B (fr)
HK (1) HK48590A (fr)
HU (1) HU197569B (fr)
IE (1) IE58228B1 (fr)
IL (1) IL74043A (fr)
IT (1) IT1214648B (fr)
LU (1) LU85725A1 (fr)
NL (1) NL193541C (fr)
NZ (1) NZ210818A (fr)
PH (1) PH23286A (fr)
PT (1) PT79818B (fr)
SE (1) SE460420B (fr)
SG (1) SG32390G (fr)
ZA (1) ZA85276B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HUT45248A (en) * 1986-01-24 1988-06-28 Sandoz Ag Process for producing 8alpha-(acylamino)-ergoline derivatives and pharmaceuticals comprising such compounds
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
US4981859A (en) * 1987-06-15 1991-01-01 Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto
DE3820159A1 (de) * 1987-06-23 1989-01-05 Sandoz Ag 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
JP2018502889A (ja) 2015-01-20 2018-02-01 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ イソエルゴリン化合物およびその使用
CN107428745A (zh) 2015-01-20 2017-12-01 Xoc制药股份有限公司 麦角灵化合物及其用途
WO2018223065A1 (fr) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Dérivés d'ergoline destinés à être utilisés en médecine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218323A (en) * 1965-11-16 Esters of i,g-dimethyl-b-ergolenyl carbamic acid
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto

Also Published As

Publication number Publication date
ES8605514A1 (es) 1986-03-16
FI850130A0 (fi) 1985-01-11
IE850064L (en) 1985-07-12
GR850065B (fr) 1985-05-03
AU583489B2 (en) 1989-05-04
PH23286A (en) 1989-06-30
AU3760985A (en) 1985-07-18
HU197569B (en) 1989-04-28
AU618290B2 (en) 1991-12-19
NL193541B (nl) 1999-09-01
NL193541C (nl) 2000-01-04
JPS60174783A (ja) 1985-09-09
IE58228B1 (en) 1993-08-11
JPH0655739B2 (ja) 1994-07-27
FR2560196B1 (fr) 1986-07-18
AU2506688A (en) 1989-02-23
CY1542A (en) 1991-03-22
PT79818B (en) 1987-01-07
GB8500454D0 (en) 1985-02-13
DE3500251C2 (de) 1995-01-26
HUT37148A (en) 1985-11-28
SE8500107D0 (sv) 1985-01-10
AU2506788A (en) 1989-03-02
US4950672A (en) 1990-08-21
PT79818A (en) 1985-02-01
FI82466B (fi) 1990-11-30
US5077298A (en) 1991-12-31
SG32390G (en) 1990-08-03
IL74043A (en) 1988-10-31
ATA5985A (de) 1990-03-15
DE3500251A1 (de) 1985-07-18
SE460420B (sv) 1989-10-09
LU85725A1 (fr) 1985-10-22
IT1214648B (it) 1990-01-18
GB2152507A (en) 1985-08-07
ZA85276B (en) 1986-08-27
AT391317B (de) 1990-09-25
DK12685A (da) 1985-07-13
BE901456A (fr) 1985-07-08
HK48590A (en) 1990-06-29
FR2560196A1 (fr) 1985-08-30
SE8500107L (sv) 1985-07-13
ES539511A0 (es) 1986-03-16
FI82466C (fi) 1991-03-11
NL8500008A (nl) 1985-08-01
NZ210818A (en) 1989-02-24
CA1245640A (fr) 1988-11-29
GB2152507B (en) 1987-07-15
AU609539B2 (en) 1991-05-02
IL74043A0 (en) 1985-04-30
DK12685D0 (da) 1985-01-10
FI850130L (fi) 1985-07-13
IT8547538A0 (it) 1985-01-11
CH664568A5 (de) 1988-03-15

Similar Documents

Publication Publication Date Title
DK169891B1 (da) 8alfa-acylaminoergoliner og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende 8alfa-acylaminoergolinerne eller syreadditionssaltene deraf samt 8alfa-acylaminoergolinerne og syreadditionssalte deraf til anvendelse til lægemidler
DK172076B1 (da) Derivater af 4-benzyl-1-(2H)-phthalazinon, fremgangsmåde til fremstilling heraf, forbindelserne til terapeutisk anvendelse, anvendelse af forbindelserne til fremstilling af lægemidler, lægemidler indeholdende forbindelserne samt fremgangsmåde til fremstilling af sådanne lægemidler
DK167572B1 (da) 6-substituerede 4-aminotetrahydrobenzoec,daaindoler, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne indoler
NO162818B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihyropyridiner.
SK279058B6 (sk) Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d
HUT74090A (en) Indole derivatives, process for producing them and pharmaceutical compositions containing them
ITMI970867A1 (it) Indazolammidi come agenti serotoninergici
FI91750B (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoista bentso-3,4-dihydropyridiinin johdosta
AU3964393A (en) Novel amidoalkyl- and imidoalkyl-piperazines
CA1203798A (fr) Esters d'acide cyproheptadine-3-carboxylique et composes ayant une configuration apparentee
IE911744A1 (en) N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
CZ325196A3 (en) Derivatives of hydroximic acid, pharmaceutical compositions containing thereof, process of their preparation and intermediates used in the preparation process
US5298503A (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkanes
US4448777A (en) 1-Phenylindazole-3-one compounds, process and intermediates for their preparation, and pharmaceutical compositions containing same
US4237135A (en) 2-(4-Ethyl-1-piperazinyl)-4-phenylquinoline, process for preparation thereof, and composition thereof
PT92594B (pt) Processo para a preparacao de derivados de ergolina
EP0157399B1 (fr) Composés (5H-dibenzo[a,d]cycloheptem-5-yl)-4-pipéridine
AU597319B2 (en) Heteroaromatic acetylenes useful as antihypertensive agents
HU192090B (en) Process for preparing new tetrazolyl derivatives and pharmaceutical compositions containing such compounds
GB2040288A (en) Derivatives of phenylethylamines
PL100615B1 (pl) Sposob wytwarzania nowych eterowych pochodnych oksymu
KR900008564B1 (ko) 신규한 8α-아실아미노에르고린의 제조방법
JPS5973589A (ja) Ｃ−ホモ−９−オキサエルゴリンの新誘導体及びそれらの塩類、これらの製造法並びにそれらを含有する薬剤
CZ278319B6 (en) 13-bromo and 13,14-dibromoergolines, process of their preparation and use
JPH0616638A (ja) ピリジン化合物およびその医薬用途